Viewing Study NCT01877005


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2026-02-25 @ 5:53 PM
Study NCT ID: NCT01877005
Status: COMPLETED
Last Update Posted: 2018-08-22
First Post: 2013-06-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma
Sponsor: The Lymphoma Academic Research Organisation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module